Literature DB >> 8872502

Secretion of type-1-fimbriae binding proteins from human neutrophil granulocytes.

A Karlsson1, C Dahlgren.   

Abstract

Granule matrix proteins secreted from human neutrophils after ionomycin stimulation were separated by SDS-PAGE, blotted onto a polyvinylidene diflouride (PVDF) membrane and overlaid with the mannose-binding lectin concanavalin A (Con A) or Escherichia coli bacteria exposing type-I-fimbriae. Four proteins of approximately 30, 40, 70 and 80 kD, respectively, derived from both the azurophil and the specific granules were shown to expose mannose-containing structures by binding of Con A. Such reactivity was also shown for a 90-kD protein from the light membrane fraction enriched in plasma membrane and secretory vesicles. When blots of granule matrix proteins were exposed to type-I-fimbriated bacteria, a total of seven proteins was recognized; four of the five Con A-binding proteins (40, 70, 80 and 90 kD) was detected also by the bacteria in addition to three proteins not detected by Con A (50, 60 and 100 kD). The role of the secreted type-1-fimbriae binding proteins as anti-adhesin candidates is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872502     DOI: 10.1007/bf01486741

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  37 in total

Review 1.  Adhesins as lectins: specificity and role in infection.

Authors:  I Ofek; N Sharon
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  A modified procedure for the determination of leukocyte alkaline phosphatase.

Authors:  L R DeChatelet; M R Cooper
Journal:  Biochem Med       Date:  1970-08

4.  Interaction between human polymorphonuclear leukocytes and two different strains of type 1 fimbriae-bearing Escherichia coli.

Authors:  L Ohman; J Hed; O Stendahl
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

5.  Subcellular localization of the large subunit of Mo1 (Mo1 alpha; formerly gp 110), a surface glycoprotein associated with neutrophil adhesion.

Authors:  R F Todd; M A Arnaout; R E Rosin; C A Crowley; W A Peters; B M Babior
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

6.  Detection of glycoprotein receptors on blotting membranes by binding of live bacteria and amplification by growth.

Authors:  A Karlsson; M Markfjäll; H Lundqvist; N Strömberg; C Dahlgren
Journal:  Anal Biochem       Date:  1995-01-01       Impact factor: 3.365

7.  RAPID CHARCOAL ASSAY FOR INTRINSIC FACTOR (IF), GASTRIC JUICE UNSATURATED B12 BINDING CAPACITY, ANTIBODY TO IF, AND SERUM UNSATURATED B12 BINDING CAPACITY.

Authors:  K S GOTTLIEBLAU; L R WASSERMAN; V HERBERT
Journal:  Blood       Date:  1965-06       Impact factor: 22.113

8.  Comparison of human lactoferrins from milk and neutrophilic leucocytes. Relative molecular mass, isoelectric point, iron-binding properties and uptake by the liver.

Authors:  N Moguilevsky; L A Retegui; P L Masson
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

9.  Iron binding to human lactoferrin alters reactivity of the protein with plant lectins.

Authors:  L Ying; P Furmanski
Journal:  Biochem Biophys Res Commun       Date:  1993-10-29       Impact factor: 3.575

10.  Prevention of degradation of human polymorphonuclear leukocyte proteins by diisopropylfluorophosphate.

Authors:  P C Amrein; T P Stossel
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

View more
  1 in total

1.  Helicobacter pylori and neutrophils: sialic acid-dependent binding to various isolated glycoconjugates.

Authors:  H Miller-Podraza; J Bergström; S Teneberg; M A Milh; M Longard; B M Olsson; L Uggla; K A Karlsson
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.